Edesa Biotech, Inc. — Director's Dealing 2015

Dec 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2015-12-22

Reporting Person: BRISSON MARY CATHERINE (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-22	Share Option (Right to Buy)	$7.24	A	10000	Acquired	2022-12-18	Common Shares (10000)	Direct

Footnotes

F1: Option grant under the 2013 Fixed Share Option Plan (the "Plan"), which shall vest as to one-third immediately, as to one-third on December 22, 2016 and as to the remaining one-third on June 22, 2017.